Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04285840 · ClinicalTrials.gov registry record · NA
Arterial Versus Venous Activated Clotting Time (ACT) Measurements During Atrial Fibrillation Ablations
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT04285840 is a NA study that has completed, run by Duke University. The registered enrollment target is 40 participants.
The verdict
NCT04285840, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Activated clotting times (ACTs) are routinely measured throughout atrial fibrillation ablations to monitor anticoagulation prior to and after heparin administration. Routinely, ACTs are obtained from an arterial line established prior to heparin administration. With technological advances, the cardiac intervention team is interested in eliminating the need for arterial lines for noninvasive monitoring devices; eliminating arterial lines could decrease the risk of bleeding, infection, and pain. Since procedural access requires femoral vein catheterization, obtaining ACTs through the venous sheath would not pose additional risks to the patient. In this study it proposed to draw paired arterial and venous ACT samples in ablation procedures to compare the agreement between venous and arterial ACTs for adequate patient treatment planning.
Interventions
- OTHER Venous ACT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-02-10 |
| Est. Completion | 2020-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04285840
The ClinicalTrials.gov registry entry for NCT04285840 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Venous ACT is the first listed.
NCT04285840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04285840 about?
NCT04285840 is a clinical study titled "Arterial Versus Venous Activated Clotting Time (ACT) Measurements During Atrial Fibrillation Ablations". Activated clotting times (ACTs) are routinely measured throughout atrial fibrillation ablations to monitor anticoagulation prior to and after heparin administration. Routinely, ACTs are obtained from an arterial line established prior to heparin administration. With technological advances, the cardi...
What is the current status of trial NCT04285840?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2020-02-10. Estimated completion is 2020-07-01.
What interventions are being tested in trial NCT04285840?
The interventions under investigation include: Venous ACT (OTHER).
Who is sponsoring clinical trial NCT04285840?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.